calmidazolium has been researched along with ketamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Becker, GL; Landers, DF; Pohorecki, R; Reilly, PJ | 2 |
2 other study(ies) available for calmidazolium and ketamine
Article | Year |
---|---|
Ketamine, MK-801 or calmidazolium protects rat hippocampal energy status during in vitro ischemia.
Topics: Adenosine Triphosphate; Animals; Calmodulin; Dizocilpine Maleate; Energy Metabolism; Hippocampus; Imidazoles; In Vitro Techniques; Ischemic Attack, Transient; Ketamine; Kinetics; Rats | 1991 |
Ischemic brain injury in vitro: protective effects of NMDA receptor antagonists and calmidazolium.
Topics: Adenosine Triphosphate; Animals; Brain Ischemia; Dizocilpine Maleate; Hippocampus; Imidazoles; In Vitro Techniques; Ketamine; Rats; Receptors, N-Methyl-D-Aspartate; Time Factors | 1990 |